Advertisement

Evaluation of a Novel Multimodal Opioid-Free Postoperative Pain Management Pathway Following Robotic-Assisted Radical Prostatectomy: A Pilot Series in the Veteran Population

      Abstract

      Background

      Veterans have disproportionate risk of opioid misuse and abuse compared to the civilian population. Managing acute postoperative pain without opioids is of the utmost importance for the Veteran patient population. This pilot study evaluates a novel multimodal opioid-free pain control regimen by assessing postoperative pain in Veterans undergoing robotic-assisted radical prostatectomy (RARP).

      Methods

      Prospective data was collected from patients undergoing RARP at a Department of Veterans Affairs Medical Center. Patients in the opioid-cohort received tramadol, hydrocodone-acetaminophen, or oxycodone-acetaminophen postoperatively. The opioid-free novel multimodal approach consisted of 100 mg gabapentin TID, 15 mg ketorolac Q6 hours, and 1 mg scheduled IV acetaminophen Q6 hours. Pain scores were collected using a visual analogue pain scale on postoperative days 0 and 1.

      Results

      Data was collected from 57 patients, 33 treated with opioids and 24 with the opioid-free pathway. There were no significant differences in demographics (P > .05) between cohorts. No significant differences were observed for preoperative and intraoperative variables (P > .05). Average postoperative day 0 pain scores for opioid-free (2.2 ± 3.1) and opioid treatments (3.1 ± 3.1) were not statistically different (P = .1321). Postoperative day 1 differences of average pain scores for opioid-free (0.9 ± 1.9) and opioid (1.6 ± 3.1) treatments were not statistically significant (P = .1647).

      Conclusions

      The novel multimodal opioid-free treatment in this study may be effectively utilized for postoperative pain during hospital recovery of Veterans undergoing RARP. Future directions include a randomized control clinical trial in the general population.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mattson CL
        • Tanz LJ
        • Quinn K
        • Kariisa M
        • Patel P
        • Davis NL
        Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019.
        Morb Mortal Wkly Rep. 2021; 70: 202-207https://doi.org/10.15585/mmwr.mm7006a4
        • Bohnert AS
        • Ilgen MA
        • Galea S
        • McCarthy JF
        • Blow FC
        Accidental poisoning mortality among patients in the department of veterans affairs health system.
        Med Care. 2011; 49: 393-396https://doi.org/10.1097/MLR.0b013e318202aa27
        • Gellad WF
        • Good CB
        • Shulkin DJ
        Addressing the opioid epidemic in the United States.
        JAMA. 2017; 177: 611https://doi.org/10.1001/jamainternmed.2017.0147
        • Lin LA
        • Peltzman T
        • McCarthy JF
        • et al.
        Changing trends in opioid overdose deaths and prescription opioid receipt among veterans.
        Am J Prev Med. 2019; 57: 106-110https://doi.org/10.1016/j.amepre.2019.01.016
        • Brummett CM
        • Waljee JF
        • Goesling J
        • et al.
        New persistent opioid use after minor and major surgical procedures in US adults.
        JAMA Surg. 2017; 152e170504https://doi.org/10.1001/jamasurg.2017.0504
        • Namiranian K
        • Siglin J
        • Sorkin JD.
        The incidence of persistent postoperative opioid use among U.S. veterans: a national study to identify risk factors.
        J Clin Anesth. 2021; 68110079https://doi.org/10.1016/j.jclinane.2020.110079
        • Pathak RA
        • Hemal AK
        Evaluating the opioid epidemic: a urologist's promise to curb the crisis.
        Transl Androl Urol. 2021; 10: 19-21https://doi.org/10.21037/tau-2020-899
        • Hallway A
        • Vu J
        • Lee J
        • et al.
        Patient satisfaction and pain control using an opioid-sparing postoperative pathway.
        J Am Coll Surg. 2019; 229: 316-322https://doi.org/10.1016/j.jamcollsurg.2019.04.020
        • Patel HD
        • Faisal FA
        • Patel ND
        • et al.
        Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the opioid reduction intervention for open, laparoscopic, and endoscopic surgery (ORIOLES) initiative.
        BJU Intl. 2020; 125: 426-432https://doi.org/10.1111/bju.14932
        • Talwar R
        • Xia L
        • Serna J
        • et al.
        Preventing excess narcotic prescriptions in new robotic surgery discharges: the PENN prospective cohort quality improvement initiative.
        J Endourol. 2019; 34: 48-53https://doi.org/10.1089/end.2019.0362
        • Dal MF
        • Aiello L
        • Pavarin P
        • Zattoni F.
        Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel '4-point' technique-results of a prospective, randomized study [published correction appears in J Robot Surg. 2018 Aug 14;:].
        J Robot Surg. 2019; 13: 147-151https://doi.org/10.1007/s11701-018-0858-6
        • Trabulsi EJ
        • Patel J
        • Viscusi ER
        • et al.
        Preemptive multimodal pain regimen reduces opioid analgesia for patients undergoing robotic-assisted laparoscopic radical prostatectomy.
        Urology. 2010; 76: 1122-1124https://doi.org/10.1016/j.urology.2010.03.052
        • Horodyski L
        • Ball B
        • Emile C
        • et al.
        Safe transition to opioid-free pathway after robotic-assisted laparoscopic prostatectomy.
        J Rob Surg. 2021; https://doi.org/10.1007/s11701-021-01237-0
        • Kumar K
        • Kirksey MA
        • Duong S
        • et al.
        A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively.
        Anesth Analg. 2017; 125: 1749-1760https://doi.org/10.1213/ANE.0000000000002497
        • Rose MA
        • Kam PC
        Gabapentin: pharmacology and its use in pain management.
        Anesthesia. 2002; 57: 451-462https://doi.org/10.1046/j.0003-2409.2001.02399.x
        • Peng PW
        • Wijeysundera DN
        • Li CC
        Use of gabapentin for perioperative pain control—a meta-analysis.
        Pain Res Manage. 2007; 12: 85-92https://doi.org/10.1155/2007/840572
        • Hah J
        • Mackey SC
        • Schmidt P
        • et al.
        Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial.
        JAMA Surg. 2018; 153: 303https://doi.org/10.1001/jamasurg.2017.4915
      1. Acetaminophen. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com.

        • Baser O
        • Ogbomo A
        • Tan H
        • et al.
        PMH31 - evaluation of the burden of opioid abuse among US veteran patients.
        Value Health. 2015; 18: A411https://doi.org/10.1016/j.jval.2015.09.984
        • Nugent GN
        • Hendricks A
        • Nugent LB
        • et al.
        Value for taxpayers' dollars: what VA care would cost at medicare prices.
        Med Care Res Rev. 2004; 61: 495-508
        • Nugent GN
        • Hendricks A
        Estimating private sector values for VA health care: an overview.
        Med Care. 2003; 41: II2-II10